ADAG CIK: 1818838

Adagene Inc.

  • China
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
186
FY22:
149
FY23:
113
FY24:
87.8
FY25:
77.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.56
FY22:
3.08
FY23:
2.29
FY24:
1.49
FY25:
0.89
Total assets
Change from FY21 to FY25
millions USD
FY21:
190
FY22:
152
FY23:
116
FY24:
89.3
FY25:
78.3

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
29.8
FY22:
55.1
FY23:
31.5
FY24:
38.2
FY25:
25.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.13
FY22:
14.2
FY23:
13.7
FY24:
0.56
FY25:
1.19
(positive)
Change from FY21 to FY25
millions USD
FY21:
157
FY22:
83.1
FY23:
70.6
FY24:
50.5
FY25:
35.3
Total liabilities & equity
Change from FY21 to FY24
millions USD
FY21:
190
FY22:
152
FY23:
116
FY24:
89.3
FY25:
–

All amounts in millions USD Data sources:SEC EDGARTwelve Data